Answer in brief
CVE-2026-38713 records a Critical severity (CVSS 9.8) command injection vulnerability in CVE-2026-38713. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Answer in brief
CVE-2026-38713 records a Critical severity (CVSS 9.8) command injection vulnerability in CVE-2026-38713. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Command Injection describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2026-38713 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
TR1200 v2.4.15, TR3000 v2.4.21, WR300 v2.4.25, WR1200 v2.4.23, WR1300 v2.4.22, WR1500 v2.3.10, WR3000 v2.4.19, WR3600 v2.3.16, and WR6500 v2.3.15 were discovered to contain a command injection vulnerability in the ipsec_conn interface. This vulnerability allows attackers to execute arbitrary commands as root via a crafted input.
Reported by NVD (nvd).
CVE-2026-38713 records a Critical severity (CVSS 9.8) command injection vulnerability in CVE-2026-38713. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL GuardReview the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Command Injection describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2026-38713 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
TR1200 v2.4.15, TR3000 v2.4.21, WR300 v2.4.25, WR1200 v2.4.23, WR1300 v2.4.22, WR1500 v2.3.10, WR3000 v2.4.19, WR3600 v2.3.16, and WR6500 v2.3.15 were discovered to contain a command injection vulnerability in the ipsec_conn interface. This vulnerability allows attackers to execute arbitrary commands as root via a crafted input.
Reported by NVD (nvd).
CVE-2026-38713 records a Critical severity (CVSS 9.8) command injection vulnerability in CVE-2026-38713. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL Guard